Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Mar;23(1):12-20.
doi: 10.4103/jips.jips_158_22.

Comparative evaluation of the antibacterial activity of red diode laser therapy and 0.2% chlorhexidine against Aggregatibacter actinomycetemcomitans on implant healing abutments: An ex vivo study

Affiliations

Comparative evaluation of the antibacterial activity of red diode laser therapy and 0.2% chlorhexidine against Aggregatibacter actinomycetemcomitans on implant healing abutments: An ex vivo study

Soumee Sengupta et al. J Indian Prosthodont Soc. 2023 Jan-Mar.

Abstract

Aims: The intraoral microbiota has a high potential to undergo dysbiosis, causing inflammatory changes with respect to the tissues surrounding either a natural tooth or an implant. Thus, the longevity of implant prosthesis depends on a thorough implant decontamination protocol. Among all the techniques available for doing so, laser is garnering increasing popularity, owing to minimal bleeding, high efficiency, and faster healing. However, limited literature exists regarding the superiority of lasers over chlorhexidine (CHX), the indisputable gold standard antibacterial chemical agent. The aim of this study was to compare the percentage of bacterial reduction of Aggregatibacter actinomycetemcomitans from implant healing abutments post red diode laser therapy versus 0.2% CHX treatment.

Settings and design: The current study had an ex vivo, observational, case-control design.

Materials and methods: Patients reporting for the second stage of the implant surgery were taken as the source of data and the healing abutments, the clinical samples. Eleven patients were chosen with one intraoral implant serving as the test site for laser treatment and another, the control site for CHX treatment. Microbiological analysis was performed via quantitative real time polymerase chain reaction to compare the bacterial reduction percentage after each treatment.

Statistical analysis used: Repeated measures ANOVA and independent sample t test were used.

Results: The mean bacterial viability of the test group (laser) was 1.2%-1.6%, and 0.6%-1.4% for the control group (CHX). The former caused a mean bacterial reduction of 96.1% while the latter, 96.3%. Both the treatments caused a highly statistically significant reduction of viable bacterial counts (P = 0.001). However, when compared, there was no statistically significant difference in the bacterial reduction, when compared in between the two (P = 0.902).

Conclusion: Laser treatment is at par with chemical implant surface decontamination. It can help bypass the complications of CHX and revolutionize the protocols for implant surface decontamination.

Keywords: Chlorhexidine; diode laser; implant surface decontamination.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Clinical sample collection from oral cavity of study subject. (a) Intraoral left lateral view of subject post second-stage surgery of implant placement at two intraoral sites. (b) Removal of the two healing abutments with the implant hex driver. (c) Collection of the two healing abutments into sterile microcentrifuge tubes prior to simple randomization for allotment to test and control groups
Figure 2
Figure 2
Procedure for carrying out laser treatment on test sample. (a) Protocol of laser treatment followed with initial energy output of 0 J/cm2 reaching a maximum of 703.125 J/cm2 by the end of Phase B for samples from test site undergoing laser treatment. (b) Healing abutment from test site kept stable; dappen dish manually rotated slowly for uniform exposure of laser light to all the surfaces of the healing abutment
Figure 3
Figure 3
Procedure for carrying out chlorhexidine treatment on control sample. (a) Sample from control site submerged in 1 mL of 0.2% chlorhexidine digluconate. (b) After 30 seconds, sample held gently with a sterile bracket holder and washed with water lightly to remove traces of CHX. CHX: Chlorhexidine
Figure 4
Figure 4
The final sample solutions from each patient. Phase A: LD✓Ua, LDxUa, CHXD✓Ua, CHXDxUa. Phase B: LD✓Tb, LDxTb, CHXD✓Tb, CHXDxTb. CHX: Chlorhexidine
Figure 5
Figure 5
Exposure of sample solutions to blue LED light after application of viability dye, PMAxx. LED: Light-emitting diode
Graph 1
Graph 1
Mean VBC of laser and CHX groups before and after treatment. VBC: Viable bacterial count, CHX: Chlorhexidine
Graph 2
Graph 2
Mean BVR of laser and CHX groups before and after treatment. BVR: Bacterial viability ratio, CHX: Chlorhexidine
Graph 3
Graph 3
Mean difference in the bacterial reduction percentage between laser and CHX treatments. CHX: Chlorhexidine
Graph 4
Graph 4
Mean bacterial viability ratio of samples after laser and CHX treatments. CHX: Chlorhexidine

Similar articles

References

    1. Elani HW, Starr JR, Da Silva JD, Gallucci GO. Trends in dental implant use in the U.S., 1999-2016, and projections to 2026. J Dent Res. 2018;97:1424–30. - PMC - PubMed
    1. Gulati M, Govila V, Anand V, Anand B. Implant maintenance: A clinical update. Int Sch Res Notices. 2014;2014:908534. - PMC - PubMed
    1. Pacha-Olivenza MÁ, Tejero R, Fernández-Calderón MC, Anitua E, Troya M, González-Martín ML. Relevance of topographic parameters on the adhesion and proliferation of human gingival fibroblasts and oral bacterial strains. Biomed Res Int. 2019;2019:8456342. - PMC - PubMed
    1. Khalil D, Hultin M. An Update of Dental Implantology and Biomaterial. Mazen Ahmad Almasri: IntechOpen; 2018. [Last accessed on 2022 May 12]. Peri-implantitis microbiota. Available from: https://www.intechopen.com/chapters/62398. doi: 10.5772/intechopen.79486.
    1. Lasserre JF, Brecx MC, Toma S. Oral microbes, biofilms and their role in periodontal and peri-implant diseases. Materials (Basel) 2018;11:1802. - PMC - PubMed

Publication types

MeSH terms